NanDee 65 Posted April 19, 2019 For the first time in America since the procedure was approved for commercial use last year, scientists have successfully treated a patient for drug-resistant epilipsy with a technique called “deep brain stimulation” (DBS). DBS is a minimally-invasive surgical therapy that uses an implanted medical device, similar to a cardiac pacemaker, to deliver electrical stimulation to precisely targeted areas of the brain as adjunctive treatment for several neurological disorders – including depression. In April 2018, the FDA granted pre-market approval for Medtronic DBS therapy as adjunctive treatment for reducing the frequency of partial-onset seizures in individuals 18 years of age or older who are drug-resistant to three or more anti-epileptic medications. Full Story Share this post Link to post